[1]
Humani, T.S., Sutari, S., Triningsih, T., Ramli, M., Ritawidya, R. and Haryuni, R.D. 2017. Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancers Treatment. Journal of Mathematical and Fundamental Sciences. 49, 3 (Dec. 2017), 258-268. DOI:https://doi.org/10.5614/j.math.fund.sci.2017.49.3.4.